The new blood test can rapidly detect abnormalities in up to 50% of all known rare genetic diseases in a matter of days by analysing the pathogenicity of thousands of gene mutations at once. [ + ]

A research team has found a promising new way to enhance the effectiveness of vaccines by tapping into the potential of a specific type of immune cell. [ + ]

With DNA data and machine learning, accurate bacterial resistance predictions can be made in minutes. [ + ]

Genetics accounts for about a quarter of the differences in when children take their first steps, suggesting that some children may naturally start walking earlier or later because of their genetic propensity. [ + ]

Researchers have shown how platelet clumping can be tracked in patients with coronary artery disease (CAD), opening the door to safer, more personalised treatment. [ + ]

Researchers have discovered a new type of glycopeptide antibiotic known as saarvienin A, found to have strong activity against highly resistant bacterial strains.

The health education and research complex will house more than 1200 researchers and clinician scientists on its 36,000 m² site, spanning The University of Sydney and Royal Prince Alfred Hospital. [ + ]

Abnormal immune cells are driving ongoing intestinal inflammation that causes symptoms like diarrhoea, pain and malnutrition — even when gluten is removed from the diet. [ + ]

The AI system can accurately recognise and classify a wide variety of scents, resulting in a high-performance artificial olfaction platform that is said to surpass existing technologies. [ + ]

New research shows how an MRI scan can reveal your heart's functional age — and how unhealthy lifestyles can dramatically accelerate this figure. [ + ]

Babies who receive a RV3-BB rotavirus vaccine at birth appear to show higher levels of good bacteria in their gut, better protecting them against infection during the first weeks of life. [ + ]

The TGA has approved the first amyloid-targeting therapy for people with Alzheimer's in Australia, while Spanish researchers have presented a new family of candidate compounds for the treatment of Alzheimer's and pain. [ + ]

All equipment sales activities will pass to Cell Biosciences, with all equipment service and consumable supply requirements coming into effect on 1 July 2025. [ + ]

Three generations of the philanthropic Ainsworth family have committed a total of $50 million over 10 years to establish the Ainsworth Endometriosis Research Institute (AERI) at UNSW. [ + ]

The WA Government has announced an online directory for the state's life science sector, as well as new investment in the sector through the Future Health Research and Innovation Fund. [ + ]